Test Bank NURS 6630 Midterm
Exam (2026) comprehensive
questions and verified answers
(detailed & elaborated) ACTUAL
EXAM 2026 TEST!!
Multiple systems often dysfunction in psychiatric illnesses. - Answer-Neurotransmitter
Systems
Mental health condition affecting emotional state. - Answer-Mood Disorder
Hypomanic episodes triggered by antidepressants. - Answer-Bipolar III Disorder
Serotonin receptor blocking aiding in EPS reduction. - Answer-5HT2A Antagonism
First-generation antipsychotics with higher EPS risk. - Answer-Conventional
Antipsychotics
Newer antipsychotics with lower EPS risk. - Answer-Second-Generation Antipsychotics
Focus on norepinephrine for mood stabilization. - Answer-Norepinephrine Targeting
Contraindicated for antidepressant monotherapy. - Answer-Bipolar I
Also contraindicated for antidepressant monotherapy. - Answer-Bipolar II
Avoid antidepressants due to mood cycling risk. - Answer-Cyclothymia
Influences SSRI/SNRI treatment response. - Answer-SERT genotype
Affects serotonin levels in depression. - Answer-Norepinephrine
Norepinephrine potentiates release via specific receptors. - Answer-5HT release
Drugs can mimic or inhibit NE neuron activity. - Answer-NE neuron function
Include insomnia and concentration problems post-treatment. - Answer-Residual
symptoms
,Increases serotonin by blocking presynaptic SERT. - Answer-Fluoxetine (Prozac)
Therapeutic effects linked to somatodendritic serotonin action. - Answer-SSRI action
Both effective in treating elderly depression. - Answer-Fluvoxamine vs Sertraline
Avoid aged cheeses and fermented meats. - Answer-MAOI dietary restrictions
Previously ineffective in treating patient's depression. - Answer-Bupropion
Another ineffective antidepressant for the patient. - Answer-Venlafaxine
Caution required due to potential interactions. - Answer-Antihistamines with MAOI
Involves multiple specialties for comprehensive care. - Answer-Interdisciplinary
treatment
Residual symptoms may persist despite treatment. - Answer-Major depressive disorder
Neurotransmitter affected by antidepressant medications. - Answer-Serotonin
Not suitable for patients with bipolar disorders. - Answer-Antidepressant monotherapy
Increased risk with certain antidepressant treatments. - Answer-Mood cycling
Common side effect of some antidepressants. - Answer-Sedative-like effect
Can include dizziness and restlessness. - Answer-Withdrawal symptoms
Targeted by drugs to modulate neurotransmitter release. - Answer-Presynaptic
receptors
Indicators used to create a medical diagnosis. - Answer-Symptoms
Control of brain circuits by neurotransmitters. - Answer-Neuropharmacological
regulation
Strategies targeting symptoms for elimination. - Answer-Treatment options
Conditions increasing vulnerability to depressive disorders. - Answer-Risk factors for
depression
Monoamine oxidase inhibitor, a type of antidepressant. - Answer-MAOI
Combination of two antidepressant medications. - Answer-Dual therapy
, Physical or psychological effects from stopping medication. - Answer-Withdrawal
symptoms
Sudden stop of medication without tapering. - Answer-Abrupt discontinuation
An SSRI used to treat depression and anxiety. - Answer-Fluoxetine
Unintended effects caused by medication. - Answer-Side effects
An SNRI used for depression and anxiety. - Answer-Venlafaxine
Reduced liver function affecting drug metabolism. - Answer-Hepatic impairment
Medication used to treat fibromyalgia. - Answer-Milnacipran
Increased risk of suicidal thoughts or behavior. - Answer-Suicidality
An SNRI contraindicated in certain medical conditions. - Answer-Duloxetine
An SSRI used for panic disorder treatment. - Answer-Sertraline
An SNRI prescribed for major depressive disorder. - Answer-Desvenlafaxine
Older class of antidepressants with various side effects. - Answer-Tricyclic
antidepressants (TCAs)
Mechanism causing sedation and weight gain. - Answer-Histamine H1 receptor
blockade
Body Mass Index, a measure of body fat. - Answer-BMI
Causes blurred vision due to receptor inhibition. - Answer-Muscarinic M1 receptor
blockade
Leads to weight gain as a side effect. - Answer-Alpha 1 adrenergic receptor blockade
Results in sedation through receptor inhibition. - Answer-Muscarinic M3 receptor
blockade
Requires dietary restrictions to avoid food interactions. - Answer-MAO inhibitor
Should be avoided by patients on MAO inhibitors. - Answer-Soy products
Not safe for consumption with MAO inhibitors. - Answer-Processed meats
Exam (2026) comprehensive
questions and verified answers
(detailed & elaborated) ACTUAL
EXAM 2026 TEST!!
Multiple systems often dysfunction in psychiatric illnesses. - Answer-Neurotransmitter
Systems
Mental health condition affecting emotional state. - Answer-Mood Disorder
Hypomanic episodes triggered by antidepressants. - Answer-Bipolar III Disorder
Serotonin receptor blocking aiding in EPS reduction. - Answer-5HT2A Antagonism
First-generation antipsychotics with higher EPS risk. - Answer-Conventional
Antipsychotics
Newer antipsychotics with lower EPS risk. - Answer-Second-Generation Antipsychotics
Focus on norepinephrine for mood stabilization. - Answer-Norepinephrine Targeting
Contraindicated for antidepressant monotherapy. - Answer-Bipolar I
Also contraindicated for antidepressant monotherapy. - Answer-Bipolar II
Avoid antidepressants due to mood cycling risk. - Answer-Cyclothymia
Influences SSRI/SNRI treatment response. - Answer-SERT genotype
Affects serotonin levels in depression. - Answer-Norepinephrine
Norepinephrine potentiates release via specific receptors. - Answer-5HT release
Drugs can mimic or inhibit NE neuron activity. - Answer-NE neuron function
Include insomnia and concentration problems post-treatment. - Answer-Residual
symptoms
,Increases serotonin by blocking presynaptic SERT. - Answer-Fluoxetine (Prozac)
Therapeutic effects linked to somatodendritic serotonin action. - Answer-SSRI action
Both effective in treating elderly depression. - Answer-Fluvoxamine vs Sertraline
Avoid aged cheeses and fermented meats. - Answer-MAOI dietary restrictions
Previously ineffective in treating patient's depression. - Answer-Bupropion
Another ineffective antidepressant for the patient. - Answer-Venlafaxine
Caution required due to potential interactions. - Answer-Antihistamines with MAOI
Involves multiple specialties for comprehensive care. - Answer-Interdisciplinary
treatment
Residual symptoms may persist despite treatment. - Answer-Major depressive disorder
Neurotransmitter affected by antidepressant medications. - Answer-Serotonin
Not suitable for patients with bipolar disorders. - Answer-Antidepressant monotherapy
Increased risk with certain antidepressant treatments. - Answer-Mood cycling
Common side effect of some antidepressants. - Answer-Sedative-like effect
Can include dizziness and restlessness. - Answer-Withdrawal symptoms
Targeted by drugs to modulate neurotransmitter release. - Answer-Presynaptic
receptors
Indicators used to create a medical diagnosis. - Answer-Symptoms
Control of brain circuits by neurotransmitters. - Answer-Neuropharmacological
regulation
Strategies targeting symptoms for elimination. - Answer-Treatment options
Conditions increasing vulnerability to depressive disorders. - Answer-Risk factors for
depression
Monoamine oxidase inhibitor, a type of antidepressant. - Answer-MAOI
Combination of two antidepressant medications. - Answer-Dual therapy
, Physical or psychological effects from stopping medication. - Answer-Withdrawal
symptoms
Sudden stop of medication without tapering. - Answer-Abrupt discontinuation
An SSRI used to treat depression and anxiety. - Answer-Fluoxetine
Unintended effects caused by medication. - Answer-Side effects
An SNRI used for depression and anxiety. - Answer-Venlafaxine
Reduced liver function affecting drug metabolism. - Answer-Hepatic impairment
Medication used to treat fibromyalgia. - Answer-Milnacipran
Increased risk of suicidal thoughts or behavior. - Answer-Suicidality
An SNRI contraindicated in certain medical conditions. - Answer-Duloxetine
An SSRI used for panic disorder treatment. - Answer-Sertraline
An SNRI prescribed for major depressive disorder. - Answer-Desvenlafaxine
Older class of antidepressants with various side effects. - Answer-Tricyclic
antidepressants (TCAs)
Mechanism causing sedation and weight gain. - Answer-Histamine H1 receptor
blockade
Body Mass Index, a measure of body fat. - Answer-BMI
Causes blurred vision due to receptor inhibition. - Answer-Muscarinic M1 receptor
blockade
Leads to weight gain as a side effect. - Answer-Alpha 1 adrenergic receptor blockade
Results in sedation through receptor inhibition. - Answer-Muscarinic M3 receptor
blockade
Requires dietary restrictions to avoid food interactions. - Answer-MAO inhibitor
Should be avoided by patients on MAO inhibitors. - Answer-Soy products
Not safe for consumption with MAO inhibitors. - Answer-Processed meats
